Early-phase human RA data have shown that increased plasma and synovial levels of soluble LAG-3 in RA patients correlate with joint inflammation, bone erosion, and elevated levels of pro-inflammatory cytokines [107]. Here, LAG3 is linked to rheumatoid arthritis.